PerCP-Cy5.5 Mouse Anti-Human HLA-DR Antibody (S-R566)

Name: PerCP-Cy5.5 Mouse Anti-Human HLA-DR Antibody (S-R566)S0B5173
Brand: Starter/斯達(dá)特
Price: 630 CNY
Availability: InStock

產(chǎn)品型號(hào)：S0B5173

更新時(shí)間：2025-10-08

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：115

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

PI3K-Akt 信號(hào)通路：解碼癌細(xì)胞的 “生存引擎” 與靶向治療新方向

CCL1：被忽視的免疫信號(hào)“信使“

抗體研究如何依賴蛋白質(zhì)翻譯后修飾分析？

產(chǎn)品介紹

HLA-DR is a subtype of the human leukocyte antigen （HLA） complex, specifically classified as a class II molecule, and is encoded by genes located on chromosome 6. It plays a crucial role in the immune system by presenting peptide antigens to CD4+ T cells, which subsequently trigger adaptive immune responses, including the activation of B cells and the production of antibodies. HLA-DR is primarily expressed on antigen-presenting cells such as macrophages, dendritic cells, and B cells, and its expression levels can indicate the degree of immune system activation. This molecule is also significant in clinical settings, as it is associated with various autoimmune diseases （e.g., rheumatoid arthritis linked to HLA-DR4） and is a key factor in determining the success of organ transplants. Additionally, HLA-DR has been studied in the context of cancer immunotherapy, where its expression on tumor cells can influence the effectiveness of immune-mediated tumor suppression.

上一個(gè)：S0B5164Alexa Fluor? 647 Rat Anti-Mouse CD21/CD35 antibody (S-R717)